In this edition of Questions For Corbett James answers your questions on Iran/CIA connections, climate change duplicity, whether the conspirators think they can survive their own conspiracy and much more. Also, James answers that age-old question: why do Hollywood...
Heinz Alfred "Henry" Kissinger may not be the devil himself, but he sure acts like his emissary. Seemingly everywhere there is death, destruction, carnage, criminality and cover up, you can bet old man Kissinger won't be far behind. Which is why the Nobel Institute's...
The voting machines have decided who will be the next puppet figurehead of the Pax Americana deep state for the next four years. The circus is over and the peanut shells are being swept out of the stands. So what do we have to show for all of it? Well, I have some...
Julian Charles of TheMindRenewed.com joins us this month to discuss Being There, the 1979 film by director Hal Ashby that follows the story of Chance the Gardener, a simple man with no experience of the outside world who is suddenly thrust onto the national political...
Eat your heart out, Al Gore. Being a carbon billionaire is so passé now that we're in the age of the $100 trillion climate swindle. So the real question is who (or at least which corporate front) will be the first carbon trillionaire? Will it be a carbon...
If you had told someone a few decades ago that by 2016 the company that brought aspirin to the world and the company that brought Agent Orange to Vietnam were going to team up to control a quarter of the world's food supply, chances are you would have been labeled a...
Welcome to New World Next Week — the video series from Corbett Report and Media Monarchy that covers some of the most important developments in open source intelligence news. In this week’s episode: Story #1: Pharma Firm Mylan Faces Scrutiny Over 548% Price Increase...
Welcome to New World Next Week — the video series from Corbett Report and Media Monarchy that covers some of the most important developments in open source intelligence news. In this week’s episode: Story #1: Pharma Firm Mylan Faces Scrutiny Over 548% Price Increase...
